European Archives of Oto-Rhino-Laryngology

, Volume 273, Issue 4, pp 973–987 | Cite as

Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management

  • Jochen P. Windfuhr
  • Nicole Toepfner
  • Gregor Steffen
  • Frank Waldfahrer
  • Reinhard Berner
Head and Neck

Abstract

More than 120,000 patients are treated annually in Germany to resolve repeated episodes of acute tonsillitis. Therapy is aiming at symptom regression, avoidance of complications, reduction in the number of disease-related absences in school or at work, increased cost-effectiveness and improved quality of life. The purpose of this part of the guideline is to provide clinicians in any setting with a clinically focused multi-disciplinary guidance through different conservative treatment options in order to reduce inappropriate variation in clinical care, improve clinical outcome and reduce harm. Surgical management in terms of intracapsular as well as extracapsular tonsillectomy (i.e. tonsillotomy) is the subject of part II of this guideline. To estimate the probability of tonsillitis caused by β-hemolytic streptococci, a diagnostic scoring system according to Centor or McIsaac is suggested. If therapy is considered, a positive score of ≥3 should lead to pharyngeal swab or rapid test or culture in order to identify β-hemolytic streptococci. Routinely performed blood tests for acute tonsillitis are not indicated. After acute streptococcal tonsillitis, there is no need to repeat a pharyngeal swab or any other routine blood tests, urine examinations or cardiological diagnostics such as ECG. The determination of the antistreptolysin O-titer (ASLO titer) and other antistreptococcal antibody titers do not have any value in relation to acute tonsillitis with or without pharyngitis and should not be performed. First-line therapy of β-hemolytic streptococci consists of oral penicillin. Instead of phenoxymethylpenicillin–potassium (penicillin V potassium), also phenoxymethlpenicillin–benzathine with a clearly longer half-life can be used. Oral intake for 7 days of one of both the drugs is recommended. Alternative treatment with oral cephalosporins (e.g. cefadroxil, cefalexin) is indicated only in cases of penicillin failure, frequent recurrences, and whenever a more reliable eradication of β-hemolytic streptococci is desirable. In cases of allergy or incompatibility of penicillin, cephalosporins or macrolides (e.g. Erythromycin-estolate) are valuable alternatives.

Keywords

Tonsillitis Pharyngitis Antibiotic therapy McIsaac score Tonsillectomy Tonsillotomy 

Notes

Acknowledgments

The authors would like to thank Susanne Zapf, Marburg University Hospital, Marburg, Germany, for her invaluable help in translating this clinical guideline.

References

  1. 1.
  2. 2.
    Stelter K (2014) Erkrankungen der Gaumenmandeln im Kindesalter. Laryngo- Rhino-Otologie 93(Suppl 1):S84–102PubMedGoogle Scholar
  3. 3.
    Stelter K (2014) Tonsillitis and sore throat in children. GMS Curr Top Otorhinolaryngol Head Neck Surg 13:07Google Scholar
  4. 4.
    Bathala S, Eccles R (2013) A review on the mechanism of sore throat in tonsillitis. J Laryngol Otol 127:227–232CrossRefPubMedGoogle Scholar
  5. 5.
    Scholz H, Berner R, Duppenthaler A, Forster J, Töpfner N (2013) Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI), DGPI Handbuch: Infektionen bei Kindern und Jugendlichen, 6. überarbeitete Auflage, Infektionen durch ß-hämolysierende Streptokokken der Gruppe A. Georg Thieme Verlag, Stuttgart, pp 509–516Google Scholar
  6. 6.
    Statistisches Bundesamt Gesundheit. Diagnosedaten der Patienten (2015) und Patientinnen in Krankenhäusern (einschl. Sterbe- und Stundenfälle). Fachserie 12 Reihe 621Google Scholar
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
    Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), (AWMF) AdWMF (2010) Programm für Nationale VersorgungsLeitlinien. Methoden-Report; 4. AuflageGoogle Scholar
  12. 12.
    Kunz R, Burnand B, Schünemann HJ (2008) Das GRADE-System. Ein internationaler Ansatz zur Vereinheitlichung der Graduierung von Evidenz und Empfehlungen in Leitlinien. Der Internist 49:673–680CrossRefPubMedGoogle Scholar
  13. 13.
  14. 14.
  15. 15.
    http://www.homd.org. Accessed 1 Oct 2014
  16. 16.
    Esposito S, Blasi F, Bosis S et al (2004) Aetiology of acute pharyngitis: the role of atypical bacteria. J Med Microbiol 53:645–651CrossRefPubMedGoogle Scholar
  17. 17.
    Del Mar C (1992) Managing sore throat: a literature review. I. Making the diagnosis. Med J Aust 156:572–575PubMedGoogle Scholar
  18. 18.
    Putto A (1987) Febrile exudative tonsillitis: viral or streptococcal? Pediatrics 80:6–12PubMedGoogle Scholar
  19. 19.
    Walther LE, Ilgner J, Oehme A et al (2005) Die infektiöse Mononukleose. Hno 53:383–392 quiz 393 CrossRefPubMedGoogle Scholar
  20. 20.
    McIsaac WJ, Goel V, To T, Low DE (2000) The validity of a sore throat score in family practice. CMAJ 163:811–815PubMedPubMedCentralGoogle Scholar
  21. 21.
    McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE (2004) Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA 291:1587–1595CrossRefPubMedGoogle Scholar
  22. 22.
    Little P, Hobbs FD, Mant D, McNulty CA, Mullee M, Investigators P (2012) Incidence and clinical variables associated with streptococcal throat infections: a prospective diagnostic cohort study. Br J Gen Pract 62:e787–e794CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Rantala S (2014) Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection. Eur J Clin Microbiol Infect Dis 33:1303–1310CrossRefPubMedGoogle Scholar
  24. 24.
    Jensen A, Kilian M (2012) Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes. J Clin Microbiol 50:113–126CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Brandt C, Spellerberg B (2009) Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis 49:766–772CrossRefPubMedGoogle Scholar
  26. 26.
    Barouxm N, D’Ortenzio E, Amédéo N et al (2014) The emm-cluster typing system for Group A Streptococcus identifies epidemiologic similarities across the pacific region. Clin Infect Dis 59:e84–e92CrossRefGoogle Scholar
  27. 27.
    Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9:611–616CrossRefPubMedGoogle Scholar
  28. 28.
    Nitsche-Schmitz D, Chhatwal G (2013) Host-pathogen interactions in streptococcal immune sequelae. Curr Top Microbiol Immunol 368:155–171PubMedGoogle Scholar
  29. 29.
    Reissmann S, Gillen C, Fulde M et al (2012) Region specific and worldwide distribution of collagen-binding M proteins with PARF motifs among human pathogenic streptococcal isolates. PLoS One 7:e30122CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
  31. 31.
    Tenenbaum T (2013) Meningokokkeninfektionen. Georg Thieme Verlag, StuttgartGoogle Scholar
  32. 32.
  33. 33.
    Righini C, Karkas A, Tourniaire R et al (2014) Lemierre syndrome: study of 11 cases and literature review. Head Neck 36:1044–1051CrossRefPubMedGoogle Scholar
  34. 34.
    Gebhardt B, Herrmann K, Roessner A, Vorwerk U (2010) Differenzialdiagnostik der nekrotisierenden Tonsillitis. Laryngo- Rhino- Otologie 89:266–269CrossRefPubMedGoogle Scholar
  35. 35.
  36. 36.
    Berner R, Scholz H, Sing A (2013) Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI), DGPI Handbuch: Infektionen bei Kindern und Jugendlichen, 6. überarbeitete Auflage, Diphtherie. Georg Thieme Verlag, Stuttgart, pp 228–231Google Scholar
  37. 37.
    Chiappini E, Regoli M, Bonsignori F et al (2011) Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther 33:48–58CrossRefPubMedGoogle Scholar
  38. 38.
    Johnson DR, Kurlan R, Leckman J, Kaplan EL (2010) The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis 50:481–490CrossRefPubMedGoogle Scholar
  39. 39.
    Hill HR (2010) Group A streptococcal carrier versus acute infection: the continuing dilemma. Clin Infect Dis 50:491–492CrossRefPubMedGoogle Scholar
  40. 40.
    Sen ES, Ramanan AV (2014) How to use antistreptolysin O titre. Arch Dis Child Educ Pract Ed 99:231–237CrossRefPubMedGoogle Scholar
  41. 41.
    Silva-Costa C, Carrico JA, Ramirez M, Melo-Cristino J (2014) Scarlet fever is caused by a limited number of Streptococcus pyogenes lineages and is associated with the exotoxin genes ssa, speA and speC. Pediatr Infect Dis J 33:306–310CrossRefPubMedGoogle Scholar
  42. 42.
    Toepfner NB, Scharlach R (2014) Kinder- und Jugendarzt 45Google Scholar
  43. 43.
    Schleissner F (1912) Beiträge zur Kenntnis der Streptokokken bei Scharlach. Z Kinderheilk 3:28–64CrossRefGoogle Scholar
  44. 44.
    Lennon P, Crotty M, Fenton JE (2015) Infectious mononucleosis. BMJ 350:h1825CrossRefPubMedGoogle Scholar
  45. 45.
    Balfour HH Jr, Dunmire SK, Hogquist KA (2015) Infectious mononucleosis. Clin Transl Immunol 4:e33CrossRefGoogle Scholar
  46. 46.
    Vouloumanou EK, Rafailidis PI, Falagas ME (2012) Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol 19:14–20CrossRefPubMedGoogle Scholar
  47. 47.
    Shulman ST, Bisno AL, Clegg HW et al (2012) Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 55:1279–1282CrossRefPubMedGoogle Scholar
  48. 48.
    Group ESTG, Pelucchi C, Grigoryan L (2012) Guideline for the management of acute sore throat. Clin Microbiol Infect 18(Suppl 1):1–28Google Scholar
  49. 49.
    Hafner JW (2005) Evidence-based emergency medicine/rational clinical examination abstract. The clinical diagnosis of streptococcal pharyngitis. Ann Emerg Med 46:87–89CrossRefPubMedGoogle Scholar
  50. 50.
    Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K (1981) The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1:239–246CrossRefPubMedGoogle Scholar
  51. 51.
    Fine AM, Nizet V, Mandl KD (2012) Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch Intern Med 172:847–852CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    McGinn TG, Deluca J, Ahlawat SK, Mobo BH Jr, Wisnivesky JP (2003) Validation and modification of streptococcal pharyngitis clinical prediction rules. Mayo Clin Proc 78:289–293CrossRefPubMedGoogle Scholar
  53. 53.
    Little P, Hobbs FD, Moore M et al (2014) Primary care Streptococcal Management (PRISM) study: in vitro study, diagnostic cohorts and a pragmatic adaptive randomised controlled trial with nested qualitative study and cost-effectiveness study. Health Technol Assess 18:vii–xxv, 1–101Google Scholar
  54. 54.
    Fine AM, Nizet V, Mandl KD (2013) Participatory medicine: a home score for streptococcal pharyngitis enabled by real-time biosurveillance: a cohort study. Ann Intern Med 159:577–583CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Toepfner N, Berner R, Duppenthaler A, Forster J, Scholz H (2013) Tonsillopharyngitis. In: Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI), DGPI Handbuch. Infektionen bei Kindern und Jugendlichen. Georg Thieme Verlag, Stuttgart 6. überarbeitete Auflage, Seiten, pp 785–788Google Scholar
  56. 56.
    Kurtz B, Kurtz M, Roe M, Todd J (2000) Importance of inoculum size and sampling effect in rapid antigen detection for diagnosis of Streptococcus pyogenes pharyngitis. J Clin Microbiol 38:279–281PubMedPubMedCentralGoogle Scholar
  57. 57.
  58. 58.
    Lasseter GM, McNulty CA, Hobbs FD, Mant D, Little P (2011) Group PRcSMI. Effect of swab type on the analytical sensitivity of five point-of-care tests for group A streptococci. Br J Biomed Sci 68:91–94PubMedGoogle Scholar
  59. 59.
    Madurell J, Balague M, Gomez M, Cots JM, Llor C (2010) Impact of rapid antigen detection testing on antibiotic prescription in acute pharyngitis in adults. FARINGOCAT STUDY: a multicentric randomized controlled trial. BMC Fam Pract 11:25CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Ruiz-Aragon J, Rodriguez Lopez R, Molina Linde JM (2010) Evaluation of rapid methods for detecting Streptococcus pyogenes. Systematic review and meta-analysis. Anales de Pediatria 72:391–402CrossRefPubMedGoogle Scholar
  61. 61.
    Lasseter GM, McNulty CA, Richard Hobbs FD, Mant D, Little P, Investigators P (2009) In vitro evaluation of five rapid antigen detection tests for group A beta-haemolytic streptococcal sore throat infections. Fam Pract 26:437–444CrossRefPubMedGoogle Scholar
  62. 62.
    Cohen JF, Chalumeau M, Levy C et al (2012) Spectrum and inoculum size effect of a rapid antigen detection test for group A streptococcus in children with pharyngitis. PLoS One 7:e39085CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Gerber MA, Shulman ST (2004) Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev 17:571–580 table of contents CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Toepfner N, Henneke P, Berner R, Hufnagel M (2013) Impact of technical training on rapid antigen detection tests (RADT) in group A streptococcal tonsillopharyngitis. Eur J Clin Microbiol Infect Dis 32:609–611CrossRefPubMedGoogle Scholar
  65. 65.
    www.eucast.org. Accessed 1 Oct 2014
  66. 66.
    Dierksen KP, Tagg JR (2000) Haemolysin-deficient variants of Streptococcus pyogenes and S. dysgalactiae subsp. equisimilis may be overlooked as aetiological agents of pharyngitis. J Med Microbiol 49:811–816CrossRefPubMedGoogle Scholar
  67. 67.
    www.nrz-streptococcus.de. Accessed 1 Oct 2014
  68. 68.
    www.cdc.gov/streplab. Accessed 1 Oct 2014
  69. 69.
    Gerber MA, Tanz RR, Kabat W et al (1999) Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 104:911–917CrossRefPubMedGoogle Scholar
  70. 70.
    Haverkorn MJ, Valkenburg HA, Goslings WR (1971) Streptococcal pharyngitis in the general population. I. A controlled study of streptococcal pharyngitis and its complications in the Netherlands. J Infect Dis 124:339–347CrossRefPubMedGoogle Scholar
  71. 71.
    Morozumi M, Shimizu H, Matsushima Y et al (2014) Evaluation of new immunochromatographic assay kit for adenovirus detection in throat swab: comparison with culture and real-time PCR results. J Infect Chemother 20:303–306CrossRefPubMedGoogle Scholar
  72. 72.
    Schuster V, Korn K, Nadal D, Wagner H-J (2013) Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI), DGPI Handbuch: Infektionen bei Kindern und Jugendlichen, 6. überarbeitete Auflage, Epstein Barr Virus Infektionen. Georg Thieme Verlag, Stuttgart, pp 249–252Google Scholar
  73. 73.
    Gulley ML, Tang W (2008) Laboratory assays for Epstein–Barr virus-related disease. J Mol Diagn JMD 10:279–292CrossRefPubMedGoogle Scholar
  74. 74.
    Bauer G (2001) Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein–Barr virus serology. Clin Lab 47:223–230PubMedGoogle Scholar
  75. 75.
    Christensen AM, Thomsen MK, Ovesen T, Klug TE (2014) Are procalcitonin or other infection markers useful in the detection of group A streptococcal acute tonsillitis? Scand J Infect Dis 46:376–383CrossRefPubMedGoogle Scholar
  76. 76.
    Hjortdahl P, Melbye H (1994) Does near-to-patient testing contribute to the diagnosis of streptococcal pharyngitis in adults? Scand J Prim Health Care 12:70–76CrossRefPubMedGoogle Scholar
  77. 77.
    Gulich M, Triebel T, Zeitler HP (2002) Development and validation of a simple, two-step algorithm to identify streptococcal infection in adults with sore throat. Eur J Gen Pract 8:57–61CrossRefGoogle Scholar
  78. 78.
    Lindbaek M, Hoiby EA, Lermark G, Steinsholt IM, Hjortdahl P (2005) Clinical symptoms and signs in sore throat patients with large colony variant beta-haemolytic streptococci groups C or G versus group A. Br J Gen Pract 55:615–619PubMedPubMedCentralGoogle Scholar
  79. 79.
    Sierig G, Cywes C, Wessels MR, Ashbaugh CD (2003) Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci. Infect Immun 71:446–455CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Nava A, Robles G, Mendoza AC et al (2007) Correlation between serum levels of antistreptolysin O and C reactive protein. Rev Alerg Mex 54:201–204PubMedGoogle Scholar
  81. 81.
    Sethi S, Kaushik K, Mohandas K, Sengupta C, Singh S, Sharma M (2003) Anti-streptolysin O titers in normal healthy children of 5–15 years. Indian Pediatr 40:1068–1071PubMedGoogle Scholar
  82. 82.
    Servizio sanitario regionale Emilia-Romagna. Faringotonsillite in etá pediatrica; Linea guida regionale. Bologna ISsrJ. http://asr.regione.emilia-romagna.it/wcm/asr/collana_dossier/doss153/link/doss153.pdf
  83. 83.
    Powell J, Wilson JA (2012) An evidence-based review of peritonsillar abscess. Clin Otolaryngol 37:136–145CrossRefPubMedGoogle Scholar
  84. 84.
  85. 85.
  86. 86.
    Spinks A, Glasziou PP, Del Mar CB (2013) Antibiotics for sore throat. Cochrane Database Syst Rev 11:CD000023PubMedGoogle Scholar
  87. 87.
    Zwart S, Sachs AP, Ruijs GJ, Gubbels JW, Hoes AW, de Melker RA (2000) Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults. BMJ 320:150–154CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Little P, Gould C, Williamson I, Warner G, Gantley M, Kinmonth AL (1997) Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 315:350–352CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    Howe RW, Millar MR, Coast J, Whitfield M, Peters TJ, Brookes S (1997) A randomized controlled trial of antibiotics on symptom resolution in patients presenting to their general practitioner with a sore throat. Br J Gen Pract 47:280–284PubMedPubMedCentralGoogle Scholar
  90. 90.
    Zwart S, Rovers MM, de Melker RA, Hoes AW (2003) Penicillin for acute sore throat in children: randomised, double blind trial. BMJ 327:1324CrossRefPubMedPubMedCentralGoogle Scholar
  91. 91.
    Dagnelie CF, van der Graaf Y, De Melker RA (1996) Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J Gen Pract 46:589–593PubMedPubMedCentralGoogle Scholar
  92. 92.
    Wannamaker LW, Rammelkamp CH Jr, Denny FW et al (1951) Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med 10:673–695CrossRefPubMedGoogle Scholar
  93. 93.
    Denny FW, Wannamaker LW, Brink WR, Rammelkamp CH Jr, Custer EA (1950) Prevention of rheumatic fever; treatment of the preceding streptococcic infection. J Am Med Assoc 143:151–153CrossRefPubMedGoogle Scholar
  94. 94.
    Chamovitz R, Catanzaro FJ, Stetson CA, Rammelkamp CH Jr (1954) Prevention of rheumatic fever by treatment of previous streptococcal infections. I. Evaluation of benzathine penicillin G. New Engl J Med 251:466–471CrossRefPubMedGoogle Scholar
  95. 95.
    Pichichero ME, Casey JR (2007) Bacterial eradication rates with shortened courses of 2nd- and 3rd-generation cephalosporins versus 10 days of penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Diagn Microbiol Infect Dis 59:127–130CrossRefPubMedGoogle Scholar
  96. 96.
    Gerber MA, Baltimore RS, Eaton CB et al (2009) Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on functional genomics and translational biology, and the Interdisciplinary Council on quality of care and outcomes research: endorsed by the American Academy of Pediatrics. Circulation 119:1541–1551CrossRefPubMedGoogle Scholar
  97. 97.
    Bisno AL, Stevens DL (2005) Streptococcus pyogenes. Elsevier Churchill Livingstone, PhiladelphiaGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Jochen P. Windfuhr
    • 1
  • Nicole Toepfner
    • 2
  • Gregor Steffen
    • 3
  • Frank Waldfahrer
    • 4
  • Reinhard Berner
    • 2
  1. 1.Department of Otorhinolaryngology, Plastic Head and Neck SurgeryKliniken Maria HilfMönchengladbachGermany
  2. 2.Department of PediatricsUniversity Hospital Carl Gustav Carus, Technische Universität DresdenDresdenGermany
  3. 3.Private PracticeCologneGermany
  4. 4.Department of Otolaryngology, Head and Neck SurgeryUniversity Hospital of ErlangenErlangenGermany

Personalised recommendations